SITC Archive Library

Immunotherapy is revolutionizing how doctors treat certain types of cancer. Sometimes referred to as biologic therapy or biotherapy, immunotherapy harnesses the potential of the body's own immune system to fight cancer. Training the immune system to respond to cancer has the potential for a more lasting response that can extend beyond the end of treatment, making it very different from other types of cancer treatments. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), provides current, medically accurate information intended for patients and caregivers to outline available immunotherapy options, the role of the immune system in cancer treatment and what to expect while undergoing treatment. This resource also lists ongoing immunotherapy clinical trials by cancer type as a reference (as of December 2018). Also available is the Spanish language edition.

#BoneCancers#BrainCancers#BreastCancers#ColorectalCancer
#GastrointestinalCancers#GenitourinaryCancers#GynecologicCancers
#HeadandNeckCancers#HematologicMalignancies#LungCancers
#Neuroblastoma#ProstateCancer#SkinCancers#SITC#AdverseEvents
#SideEffects#ImmuneCheckpointInhibitors#Vaccines#Patient#PatientAdvocate
#2018#Bcells#Tcells#Naturalkillercells#RenalCellCarcinoma#ClinicalTrials
#Biomarkers#Pembrolizumab#AdoptiveCellTherapy#Leukemia#Lymphoma
#Cytokines#BladderCancer#CervicalCancer#Melanoma#Myeloma#Blinatumomab
#Avelumab#Atezolizumab#BispecificAntibodies#Cemiplimab#Durvalumab
#Ipilimumab#Nivolumab